Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

SHOCKING: What to expect from johnson johnson s q3 2025 earnings report - You Need To See This

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) is a healthcare company recognized for its leadership in pharmaceuticals, medical technologies, and consumer health products. Valued at a market cap of $428 billion, the company focuses on improving human health and well-being through scientific innovation, patient-centered care, and a commitment to addressing some of the world’s most pressing health challenges. The company is expected to announce its fiscal Q3 earnings for 2025 before the market opens on Tuesday, Oct. 14.

Before this event, analysts project this healthcare giant to report a profit of $2.78 per share, up 14.9% from $2.42 per share in the year-ago quarter. The company has a promising trajectory of consistently beating Wall Street’s bottom-line estimates in each of the last four quarters. Its earnings of $2.77 per share in the previous quarter topped the consensus estimates by 4.1%.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.